000 07181cam a2201021 i 4500
001 ocn868511726
003 OCoLC
005 20171224114524.0
006 m o d
007 cr |||||||||||
008 140117s2014 enk ob 001 0 eng
010 _a 2014002242
040 _aDLC
_beng
_erda
_epn
_cDLC
_dYDX
_dMHW
_dN$T
_dDG1
_dCUS
_dUKMGB
_dYDXCP
_dOCLCF
_dNLGGC
_dE7B
_dCDX
_dEBLCP
_dDEBSZ
_dCOO
_dOCLCQ
_dOCLCO
_dLOA
_dDG1
016 7 _a016697425
_2Uk
019 _a875820397
_a878148990
_a960202546
_a961516735
_a962726974
020 _a9781118820148
_q(ePub)
020 _a1118820142
_q(ePub)
020 _a9781118820179
_q(Adobe PDF)
020 _a1118820177
_q(Adobe PDF)
020 _a9781118820186
_q(electronic bk.)
020 _a1118820185
_q(electronic bk.)
020 _a0470671041
020 _a9780470671047
020 _z9780470671047
_q(cloth)
029 1 _aDEBSZ
_b431662967
029 1 _aGBVCP
_b813902444
029 1 _aNZ1
_b15624996
029 1 _aNZ1
_b15920442
029 1 _aAU@
_b000052429159
035 _a(OCoLC)868511726
_z(OCoLC)875820397
_z(OCoLC)878148990
_z(OCoLC)960202546
_z(OCoLC)961516735
_z(OCoLC)962726974
042 _apcc
050 0 0 _aRM302.5
060 1 0 _aQV 771
072 7 _aBUS
_x032000
_2bisacsh
072 7 _aSOC
_x000000
_2bisacsh
082 0 0 _a363.19/463
_223
049 _aMAIN
130 0 _aPharmacovigliance.
245 1 0 _aMann's pharmacovigilance /
_cedited by Elizabeth B. Andrews, Nicholas Moore.
250 _aThird edition.
264 1 _aChichester, West Sussex, UK ;
_aHoboken, NJ :
_bWiley Blackwell,
_c2014.
300 _a1 online resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPreceded by Pharmacovigilance / editors, Ronald D. Mann, Elizabeth B. Andrews. 2nd ed. c2007.
504 _aIncludes bibliographical references and index.
588 0 _aPrint version record and CIP data provided by publisher.
520 _aMann's Pharmacovigilance is the definitive reference for the science of detection, assessment, understanding and prevention of the adverse effects of medicines, including vaccines and biologics. Pharmacovigilance is increasingly important in improving drug safety for patients and reducing risk within the practice of pharmaceutical medicine. This new third edition covers the regulatory basis and the practice of pharmacovigilance and spontaneous adverse event reporting throughout the world.
505 0 _aCover; Title page; Copyright page; Contents; Contributors; Foreword; 1: Introduction: Updated from Second Edition; Background; Diagnosing Adverse Drug Reactions; Current Methods of Pharmacovigilance; Hypothesis-Generating Methods; Spontaneous Adverse Drug Reaction Reporting; Prescription-Event Monitoring; Other Hypothesis-Generating Methods; Hypothesis-Testing Methods; Conclusion; References; 2: History of Pharmacovigilance; Early History of Drug Safety; Recent History; Pre-1962; Turning Point: The Federal Food, Drug and Cosmetics Act; Gradual Increase in Regulatory Authority.
505 8 _aTectonic Shift: ThalidomidePost-Thalidomide Evolution of Regulation; United States of America; United Kingdom; Germany; Scandinavia; Japan; World Health Organization; France; Special Issues in Pharmacovigilance; Examples of Drugs that were Withdrawn from the Market; Bendectin; Thalidomide: Today's Approved Uses; Pharmacovigilance is Not Just for Regulators; References; Part I: The Regulatory Basis of Pharmacovigilance; 3: Legal Basis: European Union; Introduction; Reorganization of the European Union Regulatory System.
505 8 _aObligations of being a Marketing Authorization Holder and being Granted a Marketing AuthorizationSignal Detection and Risk Management; Reporting Requirements; Transparency and Communication; Pharmacovigilance Enforcement; Further Information about Proposed New Legislation and Guidelines; 4: Ethical Oversight, Consent, and Confidentiality; Introduction; Practical Implications of Ethical Oversight; The Privacy and Security of Health Data; The Linkage of Electronic Health Data; The Conduct of Scientifically Sound Studies; Ethical Oversight and Privacy Law and Resulting Dilemmas; The Common Rule.
505 8 _aState LawsThe Health Insurance Portability and Accountability Act; Dilemmas Arising from the Health Insurance Portability and Accountability Act; Directions for Future Ethical Oversight and Privacy Provisions; References; 5: Pharmacovigilance-Related Topics at the Level of the International Conference on Harmonisation1; Introduction; The International Conference on Harmonisation Step Process; ICH Step 1: Development of Draft Consensus ICH Guideline or Recommendations; ICH Step 2: Confirmation of Six Party Consensus; ICH Step 3: Regulatory Consultation.
505 8 _aICH Step 4: Adoption of Tripartite ICH Guideline or RecommendationsICH Step 5: Implementation of ICH Guideline or Recommendations; Pharmacovigilance-Related International Conference on Harmonisation Topics; Topic ICH-E2A: Clinical Safety Data Management -- Definitions and Standards for Expedited Reporting; ICH-E2D Topic: Post-Approval Safety Management -- Definitions and Standards for Expedited Reporting; ICH-E2B Topic: Clinical Safety Data Management -- Data Elements for Transmission of Individual Case Safety Reports.
505 8 _aICH-E2C Topic: Clinical Safety Data Management -- Periodic Benefit-Risk Evaluation Report (PBRER).
650 0 _aPharmacovigilance.
650 0 _aDrug-Related Side Effects and Adverse Reactions
_vclassification.
650 0 _aInternationality.
650 0 _aPharmacoepidemiology
_vMethods.
650 0 _aProduct Surveillance, Postmarketing.
650 2 _aPharmacovigilance.
650 2 _aDrug-Related Side Effects and Adverse Reactions
_xclassification.
650 2 _aInternationality.
650 2 _aPharmacoepidemiology
_xmethods.
650 2 _aProduct Surveillance, Postmarketing.
650 4 _aDrug-Related Side Effects and Adverse Reactions
_xclassification.
650 4 _aInternationality.
650 4 _aPharmacoepidemiology
_xmethods.
650 4 _aPharmacovigilance.
650 4 _aProduct Surveillance, Postmarketing.
650 7 _aBUSINESS & ECONOMICS
_xInfrastructure.
_2bisacsh
650 7 _aSOCIAL SCIENCE
_xGeneral.
_2bisacsh
650 7 _aPharmacoepidemiology.
_2fast
_0(OCoLC)fst01060242
655 4 _aElectronic books.
655 0 _aElectronic books.
700 1 _aAndrews, Elizabeth B.,
_eeditor.
700 1 _aMoore, Nicholas,
_eeditor.
776 0 8 _iPrint version:
_bThird edition.
_dChichester, West Sussex, UK : John Wiley & Sons Inc., 2014
_z9780470671047
_w(DLC) 2014000062
856 4 0 _uhttp://onlinelibrary.wiley.com/book/10.1002/9781118820186
_zWiley Online Library
938 _aCoutts Information Services
_bCOUT
_n28112612
938 _aEBL - Ebook Library
_bEBLB
_nEBL1662669
938 _aebrary
_bEBRY
_nebr10856801
938 _aEBSCOhost
_bEBSC
_n752698
938 _aYBP Library Services
_bYANK
_n11072743
938 _aYBP Library Services
_bYANK
_n11744590
938 _aYBP Library Services
_bYANK
_n11751003
994 _a92
_bDG1
999 _c13234
_d13234